Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation

Vaccarino, V.; Badimon, L.; Bremner, J. D.; Cenko, E.; Cubedo, J.; Dorobantu, M.; Duncker, D. J.; Koller, A.; Manfrini, O.; Milicic, D.; Padro, T.; Pries, A. R.; Quyyumi, A. A.; Tousoulis, D.; Trifunovic, D.; Vasiljevic, Z.; De Wit, C.; Bugiardini, R.; Carneiro, A. V.

doi:10.1093/eurheartj/ehy913

Article (Scientific journals)

Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation

Vaccarino, V.; Badimon, L.; Bremner, J. D. et al.

2020 • In European Heart Journal, 41 (17), p. 1687-1696

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/255324

DOI
10.1093/eurheartj/ehy913

PubMed
30698764

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

ehy913.pdf

Publisher postprint (566 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Vaccarino, V.; Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road Northeast, Atlanta, GA 30322, United States, Department of Medicine (Cardiology), Emory University School of Medicine, 1518 Clifton Road Northeast, Atlanta, GA 30322, United States

Badimon, L.; Cardiovascular Program (ICCC), IR-Hospital de la Santa Creu i Sant Pau, CiberCV-Institute Carlos III, Autonomous University of Barcelona, C/Sant Antoni Maria Claret, 167, Barcelona, 08025, Spain

Bremner, J. D.; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Drive Northeast, Atlanta, GA 30329, United States, Department of Radiology, Emory University School of Medicine, 1364 Clifton Road Northeast, Atlanta, GA 30322, United States, Atlanta Veterans Administration Medical Center, 670 Clairmont Road, Decatur, GA 30033, United States

Cenko, E.; Department of Experimental Diagnostic and Specialty Medicine, University of Bologna, Via Giuseppe Massarenti 9, Bologna, 40138, Italy

Cubedo, J.; Cardiovascular Program (ICCC), IR-Hospital de la Santa Creu i Sant Pau, CiberCV-Institute Carlos III, Autonomous University of Barcelona, C/Sant Antoni Maria Claret, 167, Barcelona, 08025, Spain

Dorobantu, M.; Cardiology Department, University of Medicine and Pharmacy 'Carol Davila' of Bucharest, Emergency Clinical Hospital of Bucharest, Calea Floreasca 8, Sector 1, Bucuresti, 014461, Romania

Duncker, D. J.; Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Cardiovascular Research Institute COEUR, Erasmus MC, University Medical Center, Rotterdam, Dr. Molewaterplein 40, Rotterdam, 3015 GD, Netherlands

Koller, A.; Institute of Natural Sciences, University of Physical Education, Alkotas street, 44, Budapest, 1123, Hungary, Department of Physiology, New York Medical College, Valhalla, NY 10595, United States

Manfrini, O.; Department of Experimental Diagnostic and Specialty Medicine, University of Bologna, Via Giuseppe Massarenti 9, Bologna, 40138, Italy

Milicic, D.; Department for Cardiovascular Diseases, University Hospital Center Zagreb, University of Zagreb, Kispaticeva 12, Zagreb, HR-10000, Croatia

More authors (9 more)

Other collaborator :

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Language :

English

Title :

Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation

Publication date :

2020

Journal title :

European Heart Journal

ISSN :

0195-668X

eISSN :

1522-9645

Publisher :

Oxford University Press

Volume :

Issue :

Pages :

1687-1696

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 19 January 2021

Statistics

Number of views

463 (1 by ULiège)

Number of downloads

448 (1 by ULiège)

More statistics

Scopus citations^®

383

Scopus citations^®
without self-citations

374

OpenCitations

137

Bibliography

Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005;62:617-627.
Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet 2013;382: 1575-1586.
Carney RM, Freedland KE. Depression and coronary heart disease. Nat Rev Cardiol 2017;14:145-155.
Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L.; American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific statement from the American Heart Association. Circulation 2014;129: 1350-1369.
Vaccarino V, Bremner JD. Behavioral, emotional and neurobiological determinants of coronary heart disease risk in women. Neurosci Biobehav Rev 2017;74: 297-309.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
Penninx BW. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev 2017;74:277-286.
Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011;33:203-216.
Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X, Wang Y, Xu X, Yin X, Deng J, Li L, Cao S, Lu Z. Depression and the risk of coronary heart disease: A metaanalysis of prospective cohort studies. BMC Psychiatry 2014;14:371.
Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006;27: 2763-2774.
Cassano P, Fava M. Depression and public health: An overview. J Psychosom Res 2002;53:849-857.
Ziegelstein RC. Depression in patients recovering from a myocardial infarction. JAMA 2001;286:1621-1627.
Freedland KE, Carney RM. Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Med 2013;11:131.
Vaccarino V. Psychosocial risk factors in women: Special reference to depression and posttraumatic stress disorder. In: K Orth-Gomer, V Vaccarino, N Schneiderman, HC Deter, eds. Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings and Future Perspectives. Switzerland: Springer International Publishing; 2015, pp. 63-86.
Mallik S, Spertus JA, Reid KJ, Krumholz HM, Rumsfeld JS, Weintraub WS, Agarwal P, Santra M, Bidyasar S, Lichtman JH, Wenger NK, Vaccarino V; PREMIER Registry Investigators. Depressive symptoms after acute myocardial infarction: Evidence for highest rates in younger women. Arch Intern Med 2006; 166:876-883.
Vaccarino V, Shah AJ, Rooks C, Ibeanu I, Nye JA, Pimple P, Salerno A, D'Marco L, Karohl C, Bremner JD, Raggi P. Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med 2014;76:171-180.
Smolderen KG, Strait KM, Dreyer RP, D'Onofrio G, Zhou S, Lichtman JH, Geda M, Bueno H, Beltrame J, Safdar B, Krumholz HM, Spertus JA. Depressive symptoms in younger women and men with acute myocardial infarction: Insights from the VIRGO study. J Am Heart Assoc 2015;4:e001424.
Vaccarino V, Sullivan S, Hammadah M, Wilmot K, Al Mheid I, Ramadan R, Elon L, Pimple PM, Garcia EV, Nye J, Shah AJ, Alkhoder A, Levantsevych O, Gay H, Obideen M, Huang M, Lewis TT, Bremner JD, Quyyumi AA, Raggi P. Mental stress-induced-myocardial ischemia in young patients with recent myocardial infarction: Sex differences and mechanisms. Circulation 2018;137:794-805.
Cenko E, Yoon J, Kedev S, Stankovic G, Vasiljevic Z, Krljanac G, Kalpak O, Ricci B, Milicic D, Manfrini O, van der Schaar M, Badimon L, Bugiardini R. Sex differences in outcomes after STEMI: Effect modification by treatment strategy and age. JAMA Intern Med 2018;178:632-639.
Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med 2004;164:289-298.
Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, Albert CM. Depression and risk of sudden cardiac death and coronary heart disease in women: Results from the Nurses' Health Study. J Am Coll Cardiol 2009;53:950-958.
Shah AJ, Veledar E, Hong Y, Bremner JD, Vaccarino V. Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. Arch Gen Psychiatry 2011;68:1135-1142.
Wyman L, Crum RM, Celentano D. Depressed mood and cause-specific mortality: A 40-year general community assessment. Ann Epidemiol 2012;22: 638-643.
Shah AJ, Ghasemzadeh N, Zaragoza-Macias E, Patel R, Eapen DJ, Neeland IJ, Pimple PM, Zafari AM, Quyyumi AA, Vaccarino V. Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events. J Am Heart Assoc 2014;3:e000741.
Parashar S, Rumsfeld JS, Reid KJ, Buchanan D, Dawood N, Khizer S, Lichtman J, Vaccarino V; PREMIER Registry Investigators. Impact of depression on sex differences in outcome after myocardial infarction. Circ Cardiovasc Qual Outcomes 2009;2:33-40.
Parashar S, Rumsfeld JS, Spertus JA, Reid KJ, Wenger NK, Krumholz HM, Amin A, Weintraub WS, Lichtman J, Dawood N, Vaccarino V. Time course of depression and outcome of myocardial infarction. Arch Intern Med 2006;166: 2035-2043.
Leung YW, Flora DB, Gravely S, Irvine J, Carney RM, Grace SL. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: Meta-analysis. Psychosom Med 2012;74:786-801.
Spijkerman T, de Jonge P, van den Brink RH, Jansen JH, May JF, Crijns HJ, Ormel J. Depression following myocardial infarction: First-ever versus ongoing and recurrent episodes. Gen Hosp Psychiatry 2005;27:411-417.
Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de Jonge P, Davidson KW, Czajkowski SM, Jaffe AS. History of depression and survival after acute myocardial infarction. Psychosom Med 2009;71:253-259.
de Jonge P, van den Brink RH, Spijkerman TA, Ormel J. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol 2006;48:2204-2208.
Hess CN, Wang TY, McCoy LA, Messenger JC, Effron MB, Zettler ME, Henry TD, Peterson ED, Fonarow GC. Unplanned inpatient and observation rehospitalizations after acute myocardial infarction: Insights from the treatment with adenosine diphosphate receptor inhibitors: Longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study. Circulation 2016;133:493-501.
Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 2010;40:807-814.
Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J, Vaccarino V, Chan PS. The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes 2009;2:328-337.
de Jonge P, Ormel J, van den Brink RH, van Melle JP, Spijkerman TA, Kuijper A, van Veldhuisen DJ, van den Berg MP, Honig A, Crijns HJ, Schene AH. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 2006; 163:138-144.
Carney RM, Freedland KE. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009;166:410-417.
Smolderen KG, Buchanan DM, Gosch K, Whooley M, Chan PS, Vaccarino V, Parashar S, Shah AJ, Ho PM, Spertus JA. Depression treatment and 1-year mortality after acute myocardial infarction: Insights from the TRIUMPH registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status). Circulation 2017;135:1681-1689.
Huffman JC, Smith FA, Blais MA, Beiser ME, Januzzi JL, Fricchione GL. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am J Cardiol 2006;98:319-324.
Cepoiu M, McCusker J, Cole MG, Sewitch M, Belzile E, Ciampi A. Recognition of depression by non-psychiatric physicians-a systematic literature review and meta-analysis. J Gen Intern Med 2008;23:25-36.
Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: Findings from the Heart and Soul Study. Arch Intern Med 2005;165:2508-2513.
Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-461.
Rumsfeld JS, Ho PM. Depression and cardiovascular disease: A call for recognition. Circulation 2005;111:250-253.
Swardfager W, Herrmann N, Marzolini S, Saleem M, Farber SB, Kiss A, Oh PI, Lanctot KL. Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: A prospective cohort study of 195 patients with coronary artery disease. J Clin Psychiatry 2011;72:1181-1188.
Blumenthal JA, Williams RS, Wallace AG, Williams RB, Needles TL. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med 1982;44:519-527.
Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: A clinical review. Eur Heart J 2014;35:1365-1372.
Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, Huffman JC. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol 2012;109:1266-1271.
Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, Bourassa MG. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res 2000;48:471-478.
Stein MB, Cox BJ, Afifi TO, Belik SL, Sareen J. Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med 2006;36:587-596.
Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter CM, McGregor M, McCulloch D. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010;363:2611-2620.
Tully PJ, Baumeister H. Collaborative care for the treatment of comorbid depression and coronary heart disease: A systematic review and meta-analysis protocol. Syst Rev 2014;3:127.
Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. J Psychosom Res 2000;49:229-238.
Muller-Tasch T, Peters-Klimm F, Schellberg D, Holzapfel N, Barth A, Junger J, Szecsenyi J, Herzog W. Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice. J Card Fail 2007; 13:818-824.
Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: The Heart and Soul Study. JAMA 2003;290:215-221.
Dickens CM, McGowan L, Percival C, Tomenson B, Cotter L, Heagerty A, Creed FH. Contribution of depression and anxiety to impaired health-related quality of life following first myocardial infarction. Br J Psychiatry 2006;189: 367-372.
Dekker RL, Lennie TA, Albert NM, Rayens MK, Chung ML, Wu JR, Song EK, Moser DK. Depressive symptom trajectory predicts 1-year health-related quality of life in patients with heart failure. J Card Fail 2011;17:755-763.
Barnett LA, Prior JA, Kadam UT, Jordan KP. Chest pain and shortness of breath in cardiovascular disease: A prospective cohort study in UK primary care. BMJ Open 2017;7:e015857.
Hayek SS, Ko YA, Awad M, Del Mar Soto A, Ahmed H, Patel K, Yuan M, Maddox S, Gray B, Hajjari J, Sperling L, Shah A, Vaccarino V, Quyyumi AA. Depression and chest pain in patients with coronary artery disease. Int J Cardiol 2017;230:420-426.
Frasure-Smith N, Lesperance F, Irwin MR, Talajic M, Pollock BG. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav Immun 2009;23:1140-1147.
van Hecke O, Hocking LJ, Torrance N, Campbell A, Padmanabhan S, Porteous DJ, McIntosh AM, Burri AV, Tanaka H, Williams FM, Smith BH. Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study. PLoS One 2017;12: E0170653.
McCabe PJ. Psychological distress in patients diagnosed with atrial fibrillation. The state of the science. J Cardiovasc Nurs 2010;25:40-51.
Andersson T, Magnuson A, Bryngelsson IL, Frøbert O, Henriksson KM, Edvardsson N, Poçi D. All-cause mortality in 272, 186 patients hospitalized with incident atrial fibrillation 1995-2008: A Swedish nationwide long-term case-control study. Eur Heart J 2013;34:1061-1067.
von Eisenhart Rothe A, Hutt F, Baumert J, Breithardt G, Goette A, Kirchhof P, Ladwig KH. Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: A longitudinal analysis-data from the German Competence Network on Atrial Fibrillation. Europace 2015;17: 1354-1362.
Akintade BF, Chapa D, Friedmann E, Thomas SA. The influence of depression and anxiety symptoms on health-related quality of life in patients with atrial fibrillation and atrial flutter. J Cardiovasc Nurs 2015;30:66-73.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H-C, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-2962.
Phillips KP. Role of inflammation in initiation and perpetuation of atrial fibrillation: A systematic review of the published data. J Atr Fibrillation 2013;6:935.
Lange HW, Herrmann-Lingen C. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J Psychosom Res 2007;63:509-513.
Lampert R, Jamner L, Burg M, Dziura J, Brandt C, Liu H, Li F, Donovan T, Soufer R. Triggering of symptomatic atrial fibrillation by negative emotion. J Am Coll Cardiol 2014;64:1533-1534.
Graff S, Fenger-Grøn M, Christensen B, Pedersen HS, Christensen J, Li J, Vestergaard M. Long-term risk of atrial fibrillation after the death of a partner. Open Heart 2016;3:e000367.
Patel D, Mc Conkey ND, Sohaney R, Mc Neil A, Jedrzejczyk A, Armaganijan L. A systematic review of depression and anxiety in patients with atrial fibrillation: The mind-heart link. Cardiovasc Psychiatry Neurol 2013;2013:1.
Dimsdale JE. Psychological stress and cardiovascular disease. J Am Coll Cardiol 2008;51:1237-1246.
Lampert R. Mental stress and ventricular arrhythmias. Curr Cardiol Rep 2016;18: 118.
Peacock J, Whang W. Psychological distress and arrhythmia: Risk prediction and potential modifiers. Prog Cardiovasc Dis 2013;55:582-589.
Liang JJ, Huang CX, Yang B, Huang H, Wan J, Tang YH, Zhao QY. Depressive symptoms and risk factors in Chinese patients with premature ventricular contractions without structural heart disease. Clin Cardiol 2009;32:E11-E17.
Burg MM, Soufer R. Psychological stress and induced ischemic syndromes. Curr Cardiovasc Risk Rep 2014;8:377.
Soufer R. Neurocardiac interaction during stress-induced myocardial ischemia: How does the brain cope?. Circulation 2004;110:1710-1713.
Vaccarino V, Bremner JD. Traumatic stress is heartbreaking. Biol Psychiatry 2013; 74:790-792.
Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: An evaluation of the "kindling" hypothesis. Am J Psychiatry 2000;157:1243-1251.
Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg MM, Ashleigh EA, Castillo S, Peskind ER. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994;51:411-422.
Carney RM, Freedland KE, Veith RC, Cryer PE, Skala JA, Lynch T, Jaffe AS. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 1999;45:458-463.
Adell A, Trullas R, Gelpi E. Time course of changes in serotonin and noradrenaline in rat brain after predictable or unpredictable shock. Brain Res 1988;459: 54-59.
Knardahl S, Sanders BJ, Johnson AK. Effects of adrenal demedullation on stressinduced hypertension and cardiovascular responses to acute stress. Acta Physiol Scand 1988;133:477-483.
Corbalan R, Verrier R, Lown B. Psychological stress and ventricular arrhythmias during myocardial infarction in the conscious dog. Am J Cardiol 1974;34: 692-696.
van Praag HM. The cognitive paradox in posttraumatic stress disorder: A hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:923-935.
Froger N, Palazzo E, Boni C, Hanoun N, Saurini F, Joubert C, Dutriez CI, Enache M, Maccari S, Barden N, Cohen-Salmon C, Hamon M, Lanfumey L. Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J Neurosci 2004;24:2787-2796.
Weber B, Lewicka S, Deuschle M, Colla M, Vecsei P, Heuser I. Increased diurnal plasma concentrations of cortisone in depressed patients. J Clin Endocrinol Metab 2000;85:1133-1136.
Smith GS, Eyler LT. Structural neuroimaging in geriatric psychiatry. Am J Geriatr Psychiatry 2006;14:809-811.
Bremner JD. Changes in brain volume in major depression. Depression: Mind and Body 2005;2:38-46.
Kumar A, Gupta RC, Albert Thomas M, Alger J, Wyckoff N, Hwang S. Biophysical changes in normal-appearing white matter and subcortical nuclei in late-life major depression detected using magnetization transfer. Psychiatry Res 2004;130:131-140.
Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000;157: 115-118.
Vythilingam M, Heim C, Newport J, Miller AH, Anderson E, Bronen R, Brummer M, Staib L, Vermetten E, Charney DS, Nemeroff CB, Bremner JD. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 2002;159:2072-2080.
Mervaala E, Fohr J, Kononen M, Valkonen-Korhonen M, Vainio P, Partanen K, Partanen J, Tiihonen J, Viinamaki H, Karjalainen AK, Lehtonen J. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 2000; 30:117-125.
Bremner JD, Vythilingam M, Vermetten E, Vaccarino V, Charney DS. Deficits in hippocampal and anterior cingulate functioning during verbal declarative memory encoding in midlife major depression. Am J Psychiatry 2004;161:637-645.
Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, Staib LH, Charney DS. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002;51:273-279.
Kumar A, Bilker W, Lavretsky H, Gottlieb G. Volumetric asymmetries in lateonset mood disorders: An attenuation of frontal asymmetry with depression severity. Psychiatry Res 2000;100:41-47.
Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, Pham D, Kumar A. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: An MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004;161:99-108.
Lacerda AL, Keshavan MS, Hardan AY, Yorbik O, Brambilla P, Sassi RB, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Soares JC. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry 2004;55: 353-358.
Greenwald BS, Kramer-Ginsberg E, Krishnan KR, Ashtari M, Auerbach C, Patel M. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 1998;29:613-617.
Hickie I, Scott E, Wilhelm K, Brodaty H. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression-a longitudinal evaluation. Biol Psychiatry 1997.;42:367-374.
Lenze E, Cross D, McKeel D, Neuman RJ, Sheline YI. White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am J Psychiatry 1999;156:1602-1607.
Austin MP, Dougall N, Ross M, Murray C, O'Carroll RE, Moffoot A, Ebmeier KP, Goodwin GM. Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Disord 1992;26:31-43.
Biver F, Goldman S, Delvenne V, Luxen A, De Maertelaer V, Hubain P, Mendlewicz J, Lotstra F. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994;36:381-388.
Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 1997;8:1057-1061.
Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386: 824-827.
George MS, Ketter TA, Parekh PI, Rosinsky N, Ring HA, Pazzaglia PJ, Marangell LB, Callahan AM, Post RM. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci 1997;9:55-63.
Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 1997;54:364-374.
Bremner JD, Vythilingam M, Ng CK, Vermetten E, Nazeer A, Oren DA, Berman RM, Charney DS. Regional brain metabolic correlates of alphamethylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 2003;289:3125-3134.
Smith GS, Reynolds CF, Houck PR, Dew MA, Ma Y, Mulsant BH, Pollock BG. Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression. Am J Geriatr Psychiatry 2002;10: 561-567.
Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830-843.
Goodwin GM, Austin M-P, Dougall N, Ross M, Murray C, O'Caroll RE, Moffoot A, Prentice N, Ebmeier KP. State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. J Affect Disord 1993;29:243-253.
Gianaros PJ, Onyewuenyi IC, Sheu LK, Christie IC, Critchley HD. Brain systems for baroreflex suppression during stress in humans. Hum Brain Mapp 2012;33: 1700-1716.
Lane RD, Jennings JR. Hemispheric asymmetry, autonomic asymmetry and the problem of sudden cardiac death. In: RJ Davidson, K Hugdahl, eds. Brain Asymmetry. Cambridge, MA: MIT Press; 1995, pp. 271-304.
Critchley HD, Taggart P, Sutton PM, Holdright DR, Batchvarov V, Hnatkova K, Malik M, Dolan RJ. Mental stress and sudden cardiac death: Asymmetric midbrain activity as a linking mechanism. Brain 2004;128:75-85.
Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, Pitman RK. Relation between resting amygdalar activity and cardiovascular events: A longitudinal and cohort study. Lancet 2017;389:834-845.
Chida Y, Steptoe A. Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: A metaanalysis of prospective evidence. Hypertension 2010;55:1026-1032.
Critchley HD, Corfield DR, Chandler MP, Mathias CJ, Dolan RJ. Cerebral correlates of autonomic cardiovascular arousal: A functional neuroimaging investigation in humans. J Physiol 2000;523 Pt 1:259-270.
Bremner JD, Campanella C, Khan Z, Shah M, Hammadah M, Wilmot K, Al Mheid I, Lima BB, Garcia EV, Nye J, Ward L, Kutner MH, Raggi P, Pearce BD, Shah AJ, Quyyumi AA, Vaccarino V. Brain correlates of mental stress-induced myocardial ischemia. Psychosom Med 2018;80:515-525.
Critchley HD, Mathias CJ, Dolan RJ. Neuroanatomical basis for first- A nd second-order representations of bodily states. Nat Neurosci 2001;4:207-212.
Thayer JF, Hansen AL, Saus-Rose E, Johnsen BH. Heart rate variability, prefrontal neural function, and cognitive performance: The neurovisceral integration perspective on self-regulation, adaptation, and health. Ann Behav Med 2009;37: 141-153.
Wei J, Rooks C, Ramadan R, Shah AJ, Bremner JD, Quyyumi AA, Kutner M, Vaccarino V. Meta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary artery disease. Am J Cardiol 2014;114:187-192.
Arri SS, Ryan M, Redwood SR, Marber MS. Mental stress-induced myocardial ischaemia. Heart 2016;102:472-480.
Wei J, Pimple P, Shah AJ, Rooks C, Bremner JD, Nye JA, Ibeanu I, Murrah N, Shallenberger L, Raggi P, Vaccarino V. Depressive symptoms are associated with mental stress-induced myocardial ischemia after acute myocardial infarction. PLoS One 2014;9:e102986.
Burg MM, Meadows J, Shimbo D, Davidson KW, Schwartz JE, Soufer R. Confluence of depression and acute psychological stress among patients with stable coronary heart disease: Effects on myocardial perfusion. J Am Heart Assoc 2014;3:e000898.
Arrighi JA, Burg M, Cohen IS, Soufer R. Simultaneous assessment of myocardial perfusion and function during mental stress in patients with chronic coronary artery disease. J Nucl Cardiol 2003;10:267-274.
Stone PH, Krantz DS, McMahon RP, Goldberg AD, Becker LC, Chaitman BR, Taylor HA, Cohen JD, Freedland KE, Bertolet BD, Coughlan C, Pepine CJ, Kaufmann PG, Sheps DS. Relationship among mental stress-induced ischemia and ischemia during daily life and during exercise: The Psychophysiologic Investigations of Myocardial Ischemia (PIMI) study. J Am Coll Cardiol 1999;33: 1476-1484.
Ramachandruni S, Fillingim RB, McGorray SP, Schmalfuss CM, Cooper GR, Schofield RS, Sheps DS. Mental stress provokes ischemia in coronary artery disease subjects without exercise-or adenosine-induced ischemia. J Am Coll Cardiol 2006;47:987-991.
Ramadan R, Sheps D, Esteves F, Zafari AM, Bremner JD, Vaccarino V, Quyyumi AA. Myocardial ischemia during mental stress: Role of coronary artery disease burden and vasomotion. J Am Heart Assoc 2013;2:e000321.
Hammadah M, Alkhoder A, Al Mheid I, Wilmot K, Isakadze N, Abdulhadi N, Chou D, Obideen M, O'Neal WT, Sullivan S, Tahhan AS, Kelli HM, Ramadan R, Pimple P, Sandesara P, Shah AJ, Ward L, Ko YA, Sun Y, Uphoff I, Pearce B, Garcia EV, Kutner M, Bremner JD, Esteves F, Sheps DS, Raggi P, Vaccarino V, Quyyumi AA. Hemodynamic, catecholamine, vasomotor and vascular responses: Determinants of myocardial ischemia during mental stress. Int J Cardiol 2017;243:47-53.
Sullivan S, Hammadah M, Al Mheid I, Wilmot K, Ramadan R, Alkhoder A, Isakadze N, Shah A, Levantsevych O, Pimple PM, Kutner M, Ward L, Garcia EV, Nye J, Mehta PK, Lewis TT, Bremner JD, Raggi P, Quyyumi AA, Vaccarino V. Sex differences in hemodynamic and microvascular mechanisms of myocardial ischemia induced by mental stress. Arterioscler Thromb Vasc Biol 2018;38: 473-480.
Pimple P, Hammadah M, Wilmot K, Ramadan R, Al Mheid I, Levantsevych O, Sullivan S, Garcia EV, Nye J, Shah AJ, Ward L, Mehta P, Raggi P, Bremner JD, Quyyumi AA, Vaccarino V. Chest pain and mental stress-induced myocardial ischemia: Sex differences. Am J Med 2018;131:540-547.e1.
Jangpangi D, Mondal S, Bandhu R, Kataria D, Gandhi A. Alteration of heart rate variability in patients of depression. J Clin Diagn Res 2016;10: CM04-CM06.
Grippo AJ, Beltz TG, Johnson AK. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 2003;78:703-710.
Shi S, Liang J, Liu T, Yuan X, Ruan B, Sun L, Tang Y, Yang B, Hu D, Huang C. Depression increases sympathetic activity and exacerbates myocardial remodeling after myocardial infarction: Evidence from an animal experiment. PLoS One 2014;9:e101734.
Xhyheri B, Manfrini O, Mazzolini M, Pizzi C, Bugiardini R. Heart rate variability today. Prog Cardiovasc Dis 2012;55:321-331.
Manfrini O, Pizzi C, Trerè D, Fontana F, Bugiardini R. Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction. Eur Heart J 2003;24:1560-1566.
Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: The ARIC Study. Atherosclerosis Risk In Communities. Circulation 2000;102:1239-1244.
Manfrini O, Pizzi C, Viecca M, Bugiardini R. Abnormalities of cardiac autonomic nervous activity correlate with expansive coronary artery remodeling. Atherosclerosis 2008;197:183-189.
Kemp AH, Brunoni AR, Santos IS, Nunes MA, Dantas EM, Carvalho de Figueiredo R, Pereira AC, Ribeiro AL, Mill JG, Andre~ao RV, Thayer JF, Bense~nor IM, Lotufo PA. Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: An ELSA-Brasil cohort baseline study. Am J Psychiatry 2014;171:1328-1334.
Licht CM, Naarding P, Penninx BW, van der Mast RC, de Geus EJ, Comijs H. The association between depressive disorder and cardiac autonomic control in adults 60 years and older. Psychosom Med 2015;77:279-291.
Gehi A, Mangano D, Pipkin S, Browner WS, Whooley MA. Depression and heart rate variability in patients with stable coronary heart disease: Findings from the Heart and Soul Study. Arch Gen Psychiatry 2005;62:661.
Licht CM, de Geus EJ, van Dyck R, Penninx BW. Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry 2010; 68:861-868.
Huang M, Shah A, Su S, Goldberg J, Lampert RJ, Levantsevych OM, Shallenberger L, Pimple P, Bremner JD, Vaccarino V. Association of depressive symptoms and heart rate variability in vietnam war-era twins: A longitudinal twin difference study. JAMA Psychiatry 2018;75:705-712.
Vaccarino V, Lampert R, Bremner JD, Lee F, Su S, Maisano C, Murrah NV, Jones L, Jawed F, Afzal N, Ashraf A, Goldberg J. Depressive symptoms and heart rate variability: Evidence for a shared genetic substrate in a study of twins. Psychosom Med 2008;70:628-636.
Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: Mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J 2015;36:482-9c.
Raedler TJ. Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry 2011;24:519-525.
Miller AH, Raison CL. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nat Rev Immunol 2016;16:22-34.
Das UN. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 2000;215:145-152.
Francis J, Chu Y, Johnson AK, Weiss RM, Felder RB. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol Heart Circ Physiol 2004; 286:H2264-H2271.
Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BW. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology 2015;51:164-175.
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67: 446-457.
Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003;17:276-285.
Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative depression episodes predict later C-reactive protein levels: A prospective analysis. Biol Psychiatry 2012;71:15-21.
Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: A population-based longitudinal study. JAMA Psychiatry 2014;71:1121-1128.
Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies. J Affect Disord 2013;150:736-744.
Zalli A, Jovanova O, Hoogendijk WJ, Tiemeier H, Carvalho LA. Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology (Berl) 2016;233:1669-1678.
Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak-the link between depression and cardiovascular disease. Nat Rev Cardiol 2012;9: 526-539.
Savoy C, Van Lieshout RJ, Steiner M. Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease?. Acta Physiol (Oxf) 2017;219:715-727.
Badimon L, Bugiardini R, Cenko E, Cubedo J, Dorobantu M, Duncker DJ, Estruch R, Milicic D, Tousoulis D, Vasiljevic Z, Vilahur G, De Wit C, Koller A. Position paper of the European Society of Cardiology-working group of coronary pathophysiology and microcirculation: Obesity and heart disease. Eur Heart J 2017;38:1951-1958.
Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Bio 2012;32: 2045-2051.
Su S, Zhao J, Bremner JD, Miller AH, Tang W, Bouzyk M, Snieder H, Novik O, Afzal N, Goldberg J, Vaccarino V. Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ Cardiovasc Genet 2009;2:614-620.
Bufalino C, Hepgul N, Aguglia E, Pariante CM. The role of immune genes in the association between depression and inflammation: A review of recent clinical studies. Brain Behav Immun 2013;31:31-47.
Broadley AJ, Korszun A, Jones CJ, Frenneaux MP. Arterial endothelial function is impaired in treated depression. Heart 2002;88:521-523.
Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001;88:196-198, A7.
Sherwood A, Hinderliter AL, Watkins LL, Waugh RA, Blumenthal JA. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol 2005;46:656-659.
Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ, Escaned J, Koller A, Piek JJ, de Wit C. Coronary vascular regulation, remodelling, and collateralization: Mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J 2015;36:3134-3146.
Cooper DC, Tomfohr LM, Milic MS, Natarajan L, Bardwell WA, Ziegler MG, Dimsdale JE. Depressed mood and flow-mediated dilation: A systematic review and meta-analysis. Psychosom Med 2011;73:360-369.
Greenstein AS, Paranthaman R, Burns A, Jackson A, Malik RA, Baldwin RC, Heagerty AM. Cerebrovascular damage in late-life depression is associated with structural and functional abnormalities of subcutaneous small arteries. Hypertension 2010;56:734-740.
Demirtaş T, Utkan T, Karson A, Yaz?r Y, Bayramgurler D, Gacar N. The link between unpredictable chronic mild stress model for depression and vascular inflammation? Inflammation 2014;37:1432-1438.
Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, Forstermann U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoidmediated hypertension. Proc Natl Acad Sci USA 1999;96:13357-13362.
Le Melledo JM, Mahil N, Baker GB. Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder? J Psychiatry Neurosci 2004;29:414-416.
Yui K, Imataka G, Nakamura H, Ohara N, Naito Y. Eicosanoids derived from arachidonic acid and their family prostaglandins and cyclooxygenase in psychiatric disorders. Curr Neuropharmacol 2015;13:776-785.
Bouzinova EV, Wiborg O, Aalkjaer C, Matchkov VV. Role of peripheral vascular resistance for the association between major depression and cardiovascular disease. J Cardiovasc Pharmacol 2015;65:299-307.
Burg MM, Martens EJ, Collins D, Soufer R. Depression predicts elevated endothelin-1 in patients with coronary artery disease. Psychosom Med 2011;73:2-6.
Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol 2013;2013:1.
Ghiadoni L, Donald AE, Cropley M, Mullen MJ, Oakley G, Taylor M, O'Connor G, Betteridge J, Klein N, Steptoe A, Deanfield JE. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000;102:2473-2478.
Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol 2002;39:683-688.
Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997;42:290-295.
Sanner JE, Frazier L. The role of serotonin in depression and clotting in the coronary artery disease population. J Cardiovasc Nurs 2011;26:423-429.
Zafar MU, Paz-Yepes M, Shimbo D, Vilahur G, Burg MM, Chaplin W, Fuster V, Davidson KW, Badimon JJ. Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J 2010;31:1573-1582.
Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, Finkel MS, Krishnan KRR, Gaffney M, Harrison W, Califf RM, O'Connor CM; Group SAHARTS. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: The sertraline anti-depressant heart attack randomized trial (SADHART) platelet substudy. Circulation 2003;108:939-944.
Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000;20:137-140.
Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol 2006;97:1287-1291.
Geiser F, Meier C, Wegener I, Imbierowicz K, Conrad R, Liedtke R, Oldenburg J, Harbrecht U. Association between anxiety and factors of coagulation and fibrinolysis. Psychother Psychosom 2008;77:377-383.
Amadio P, Colombo GI, Tarantino E, Gianellini S, Ieraci A, Brioschi M, Banfi C, Werba JP, Parolari A, Lee FS, Tremoli E, Barbieri SS. BDNFVal66met polymorphism: A potential bridge between depression and thrombosis. Eur Heart J 2017;38:1426-1435.
Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol Psychiatry 2006;60:1304-1305.
Newberg AR, Davydow DS, Lee HB. Cerebrovascular disease basis of depression: Post-stroke depression and vascular depression. Int Rev Psychiatry 2006;18: 433-441.
Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: Mechanisms linking vascular disease with depression. Mol Psychiatry 2013; 18:963-974.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Lo llgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315-2381.
McBride CM, Puleo E, Pollak KI, Clipp EC, Woolford S, Emmons KM. Understanding the role of cancer worry in creating a "teachable moment" for multiple risk factor reduction. Soc Sci Med 2008;66:790-800.
Mykletun A, Overland S, Aarø LE, Liabø HM, Stewart R. Smoking in relation to anxiety and depression: Evidence from a large population survey: The HUNT study. Eur Psychiatry 2008;23:77-84.
Levola J, Holopainen A, Aalto M. Depression and heavy drinking occasions: A cross-sectional general population study. Addict Behav 2011;36:375-380.
Ferrer-Garcia M, Pla-Sanjuanelo J, Dakanalis A, Vilalta-Abella F, Riva G, Fernandez-Aranda F, Sanchez I, Ribas-Sabate J, Andreu-Gracia A, Escandon-Nagel N, Gomez-Tricio O, Tena V, Gutierrez-Maldonado J. Eating behavior style predicts craving and anxiety experienced in food-related virtual environments by patients with eating disorders and healthy controls. Appetite 2017; 117:284-293.
Bruch H. Psychological aspects of overeating and obesity. Psychosomatics 1964; 5:269-274.
van Strien T, Herman CP, Verheijden MW. Eating style, overeating and weight gain. A prospective 2-year follow-up study in a representative Dutch sample. Appetite 2012;59:782-789.
Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry 1998;55: 161-166.
Fergusson DM, Goodwin RD, Horwood LJ. Major depression and cigarette smoking: Results of a 21-year longitudinal study. Psychol Med 2003;33: 1357-1367.
Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. A national perspective. JAMA 1990; 264:1541-1545.
Hall SM, Mu~noz RF, Reus VI, Sees KL. Nicotine, negative affect, and depression. J Consult Clin Psychol 1993;61:761-767.
Petri E, Bacci O, Barbuti M, Pacchiarotti I, Azorin JM, Angst J, Bowden CL, Mosolov S, Vieta E, Young AH, Perugi G; BRIDGE-II-Mix Study Group. Obesity in patients with major depression is related to bipolarity and mixed features: Evidence from the BRIDGE-II-Mix study. Bipolar Disord 2017;19:458-464.
Mason TB, Lewis RJ. Profiles of binge eating: The interaction of depressive symptoms, eating styles, and body mass index. Eat Disord 2014;22:450-460.
Lee JH, Park SK, Ryoo JH, Oh CM, Mansur RB, Alfonsi JE, Cha DS, Lee Y, McIntyre RS, Jung JY. The association between insulin resistance and depression in the Korean general population. J Affect Disord 2017;208:553-559.
Pine DS, Goldstein RB, Wolk S, Weissman MM. The association between childhood depression and adulthood body mass index. Pediatrics 2001;107: 1049-1056.
Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002;110: 497-504.
Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999;22: 1071-1076.
Golden SH, Williams JE, Ford DE, Yeh HC, Paton Sanford C, Nieto FJ, Brancati FL; Atherosclerosis Risk in Communities study. Depressive symptoms and the risk of type 2 diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2004;27:429-435.
Arroyo C, Hu FB, Ryan LM, Kawachi I, Colditz GA, Speizer FE, Manson J. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004;27:129-133.
Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE, Willett WC, Ascherio A, Hu FB. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 2010;170:1884-1891.
Pan A, Sun Q, Czernichow S, Kivimaki M, Okereke OI, Lucas M, Manson JE, Ascherio A, Hu FB. Bidirectional association between depression and obesity in middle-aged and older women. Int J Obes (Lond) 2012;36:595-602.
Ngo DT, Farb MG, Kikuchi R, Karki S, Tiwari S, Bigornia SJ, Bates DO, LaValley MP, Hamburg NM, Vita JA, Hess DT, Walsh K, Gokce N. Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity. Circulation 2014;130:1072-1080.
Sorop O, Olver TD, van de Wouw J, Heinonen I, van Duin RW, Duncker DJ, Merkus D. The microcirculation: A key player in obesity-associated cardiovascular disease. Cardiovasc Res 2017;113:1035-1045.
van Agtmaal MJM, Houben AJHM, Pouwer F, Stehouwer CDA, Schram MT. Association of microvascular dysfunction with late-life depression: A systematic review and meta-analysis. JAMA Psychiatry 2017;74:729-739.
Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, Maisano C, Jones L, Murrah NV, Vaccarino V. Depressive symptoms and metabolic syndrome: Is inflammation the underlying link? Biol Psychiatry 2008;64:896-900.
Vaccarino V, McClure C, Johnson BD, Sheps DS, Bittner V, Rutledge T, Shaw LJ, Sopko G, Olson MB, Krantz DS, Parashar S, Marroquin OC, Merz CN. Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 2008;70:40-48.
Vaccarino V, Votaw J, Faber T, Veledar E, Murrah NV, Jones LR, Zhao J, Su S, Goldberg J, Raggi JP, Quyyumi AA, Sheps DS, Bremner JD. Major depression and coronary flow reserve detected by positron emission tomography. Arch Intern Med 2009;169:1668-1676.
Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 2000;157:1552-1562.
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium; Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G, Byrne EM, Blackwood DH, Boomsma DI, Cichon S, Heath AC, Holsboer F, Lucae S, Madden PA, Martin NG, McGuffin P, Muglia P, Noethen MM, Penninx BP, Pergadia ML, Potash JB, Rietschel M, Lin D, Muller-Myhsok B, Shi J, Steinberg S, Grabe HJ, Lichtenstein P, Magnusson P, Perlis RH, Preisig M, Smoller JW, Stefansson K, Uher R, Kutalik Z, Tansey KE, Teumer A, Viktorin A, Barnes MR, Bettecken T, Binder EB, Breuer R, Castro VM, Churchill SE, Coryell WH, Craddock N, Craig IW, Czamara D, De Geus EJ, Degenhardt F, Farmer AE, Fava M, Frank J, Gainer VS, Gallagher PJ, Gordon SD, Goryachev S, Gross M, Guipponi M, Henders AK, Herms S, Hickie IB, Hoefels S, Hoogendijk W, Hottenga JJ, Iosifescu DV, Ising M, Jones I, Jones L, Jung-Ying T, Knowles JA, Kohane IS, Kohli MA, Korszun A, Landen M, Lawson WB, Lewis G, Macintyre D, Maier W, Mattheisen M, McGrath PJ, McIntosh A, McLean A, Middeldorp CM, Middleton L, Montgomery GM, Murphy SN, Nauck M, Nolen WA, Nyholt DR, O'Donovan M, Oskarsson H, Pedersen N, Scheftner WA, Schulz A, Schulze TG, Shyn SI, Sigurdsson E, Slager SL, Smit JH, Stefansson H, Steffens M, Thorgeirsson T, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Vo lzke H, Weilburg JB, Willemsen G, Zitman FG, Neale B, Daly M, Levinson DF, Sullivan PF. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013;18:497-511.
Mulle JG, Vaccarino V. Cardiovascular disease, psychosocial factors, and genetics: The case of depression. Prog Cardiovasc Dis 2013;55:557-562.
Scherrer JF, Xian H, Bucholz KK, Eisen SA, Lyons MJ, Goldberg J, Tsuang M, True WR. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med 2003;65:548-557.
Su S, Lampert R, Lee F, Bremner JD, Snieder H, Jones L, Murrah NV, Goldberg J, Vaccarino V. Common genes contribute to depressive symptoms and heart rate variability: The Twins Heart Study. Twin Res Hum Genet 2010;13:1-9.
Vaccarino V, Brennan ML, Miller AH, Bremner JD, Ritchie JC, Lindau F, Veledar E, Su S, Murrah NV, Jones L, Jawed F, Dai J, Goldberg J, Hazen SL. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: A twin study. Biol Psychiatry 2008;64:476-483.
Su S, Miller AH, Snieder H, Bremner JD, Ritchie J, Maisano C, Jones L, Murrah NV, Goldberg J, Vaccarino V. Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: The Twins Heart Study. Psychosom Med 2009;71:152-158.
Crawford B, Craig Z, Mansell G, White I, Smith A, Spaull S, Imm J, Hannon E, Wood A, Yaghootkar H, Ji Y, Mullins N, Lewis CM, Mill J, Murphy TM; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. DNA methylation and inflammation marker profiles associated with a history of depression. Hum Mol Genet 2018;27:2840-2850.
Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ; West of Scotland Coronary Prevention Study Group. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: A nested case-control study. Lancet 2007;369:107-114.
Codd V, Nelson CP, Albrecht E, Mangino M, Deelen J, Buxton JL, Hottenga JJ, Fischer K, Esko T, Surakka I, Broer L, Nyholt DR, Mateo Leach I, Salo P, Hagg S, Matthews MK, Palmen J, Norata GD, O'Reilly PF, Saleheen D, Amin N, Balmforth AJ, Beekman M, de Boer RA, Bo hringer S, Braund PS, Burton PR, de Craen AJ, Denniff M, Dong Y, Douroudis K, Dubinina E, Eriksson JG, Garlaschelli K, Guo D, Hartikainen AL, Henders AK, Houwing-Duistermaat JJ, Kananen L, Karssen LC, Kettunen J, Klopp N, Lagou V, van Leeuwen EM, Madden PA, Magi R, Magnusson PK, Mannisto S, McCarthy MI, Medland SE, Mihailov E, Montgomery GW, Oostra BA, Palotie A, Peters A, Pollard H, Pouta A, Prokopenko I, Ripatti S, Salomaa V, Suchiman HE, Valdes AM, Verweij N, Vi~nuela A, Wang X, Wichmann HE, Widen E, Willemsen G, Wright MJ, Xia K, Xiao X, van Veldhuisen DJ, Catapano AL, Tobin MD, Hall AS, Blakemore AI, van Gilst WH, Zhu H, Erdmann J, Reilly MP, Kathiresan S, Schunkert H, Talmud PJ, Pedersen NL, Perola M, Ouwehand W, Kaprio J, Martin NG, van Duijn CM, Hovatta I, Gieger C, Metspalu A, Boomsma DI, Jarvelin MR, Slagboom PE, Thompson JR, Spector TD, van der Harst P, Samani NJ; CARDIoGRAM consortium. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013;45:422-427, 427e1-2.
Said MA, Eppinga RN, Hagemeijer Y, Verweij N, van der Harst P. Telomere length and risk of cardiovascular disease and cancer. J Am Coll Cardiol 2017;70: 506-507.
Wikgren M, Maripuu M, Karlsson T, Nordfjall K, Bergdahl J, Hultdin J, Del-Favero J, Roos G, Nilsson LG, Adolfsson R, Norrback KF. Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry 2012;71:294-300.
Karabatsiakis A, Kolassa IT, Kolassa S, Rudolph KL, Dietrich DE. Telomere shortening in leukocyte subpopulations in depression. BMC Psychiatry 2014;14:192.
Shaffer JA, Epel E, Kang MS, Ye S, Schwartz JE, Davidson KW, Kirkland S, Honig LS, Shimbo D. Depressive symptoms are not associated with leukocyte telomere length: Findings from the Nova Scotia Health Survey (NSHS95), a population-based study. PLoS One 2012;7:e48318.
Wium-Andersen MK, ∅rsted DD, Rode L, Bojesen SE, Nordestgaard BG. Telomere length and depression: Prospective cohort study and Mendelian randomisation study in 67 306 individuals. Br J Psychiatry 2017;210:31-38.
Whalley B, Rees K, Davies P, Bennett P, Ebrahim S, Liu Z, West R, Moxham T, Thompson DR, Taylor RS. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2011;CD002902.
Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH, Taubert KA; World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458-2473.
First MB, Williams JBW, Gibbon M. Structured Clinical Interview for DSMIV-Patient Edition (SCID-P). Washington, DC: American Psychiatric Press; 1995.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23: 56-62.
Carneiro AM, Fernandes F, Moreno RA. Hamilton depression rating scale and Montgomery-Asberg Depression Rating Scale in depressed and bipolar I patients: Psychometric properties in a Brazilian sample. Health Qual Life Outcomes 2015;13:42.
Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
Coric V, Stock EG, Pultz J, Marcus R, Sheehan DV. Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary results from a multicenter clinical trial in generalized anxiety disorder. Psychiatry (Edgmont) 2009;6:26-31.
Hirschfeld RM. The epidemiology of depression and the evolution of treatment. J Clin Psychiatry 2012;73 Suppl 1:5-9.
Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106-3116.
Davis L, Hamner M, Bremner JD. Pharmacotherapy for PTSD: Effects on PTSD symptoms and the brain. In: JD Bremner, ed. Posttraumatic Stress Disorder: From Neurobiology to Treatment. Hoboken, NJ: Wiley Blackwell; 2016. p389-412.
Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J. Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA 2010;303:47-53.
Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Møller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL, Krogh J, Ebert SE, Timm A, Lindschou J, Gluud C. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry 2017;17:58.
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet 2018;391:1357-1366.
Weeke P, Jensen A, Folke F, Gislason GH, Olesen JB, Andersson C, Fosbøl EL, Larsen JK, Lippert FK, Nielsen SL, Gerds T, Andersen PK, Kanters JK, Poulsen HE, Pehrson S, Køber L, Torp-Pedersen C. Antidepressant use and risk of outof-hospital cardiac arrest: A nationwide case-time-control study. Clin Pharmacol Ther 2012;92:72-79.
Kvam S, Kleppe CL, Nordhus IH, Hovland A. Exercise as a treatment for depression: A meta-analysis. J Affect Disord 2016;202:67-86.
Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR. Effects of exercise training on older patients with major depression. Arch Intern Med 1999;159:2349-2356.
Rutledge T, Redwine LS, Linke SE, Mills PJ. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 2013;75: 335-349.
Blumenthal JA, Sherwood A, Smith PJ, Watkins L, Mabe S, Kraus WE, Ingle K, Miller P, Hinderliter A. Enhancing cardiac rehabilitation with stress management training: A randomized, clinical efficacy trial. Circulation 2016;133: 1341-1350.